| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is making significant advancements in product and service development, particularly through the expansion of its manufacturing capacity and a focus on innovative treatments for obesity and diabetes. The company is investing in a new facility in the Netherlands to increase production capabilities and is advancing obesity drug development, showcasing promising clinical trial results and the potential for FDA approvals. The emphasis on innovation in healthcare, especially with drugs like Tirzepatide, highlights Eli Lilly's commitment to addressing pressing health issues. Overall, these developments position the company favorably in a competitive market. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.6 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at 0 on 2025-11-08. The forces of and () will drive down the price. The forces of Valuation Sentiment (0), Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.8) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-08 | 0%(0%) | 0 | 0% | 0.6 | 3.8 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | 6 | |||||||
| 2025-11-06 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | 0.3 | |||||||
| 2025-11-05 | 0%(0.1%) | 0 | 0% | 0.6 | 4.7 | -1 | |||||||
| 2025-11-04 | 0%(0.1%) | 0 | 0% | 0.6 | 4.7 | 5.3 | |||||||
| 2025-11-03 | 0%(0.1%) | 0 | 0% | 0.6 | 4.8 | -1 | |||||||
| 2025-11-02 | 0%(0.1%) | 0 | 0% | 0.6 | 4.7 | -1 | |||||||
| 2025-11-01 | 0%(0.1%) | 0 | 0% | 0.6 | 4.6 | -1 | |||||||
| 2025-10-31 | 0%(0.1%) | 0 | 0% | 0.6 | 4.4 | 6.5 | |||||||
| 2025-10-30 | 1%(0.1%) | 0 | 0% | 0.6 | 4.4 | 6.8 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-08 17:01:46 Changes in regulation, including pricing deals with the government, could impact Eli Lilly's operations and market strategy. |
| 2025-11-08 17:01:46 Predictions regarding Eli Lilly's potential future valuation suggest significant growth, indicating confidence among analysts. |
| 2025-11-08 17:01:46 Eli Lilly has formed strategic partnerships that enhance its market position and lead to favorable agreements. |
| 2025-11-08 17:01:46 The excellent third-quarter results of Eli Lilly are driven by innovative products, reinforcing a positive earnings outlook. |
| 2025-11-08 17:01:46 Eli Lilly's stocks have shown resilience and growth potential amidst market volatility, indicating strong performance. |